AlphaQuest’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,989
Closed -$64.5K 1409
2025
Q4
$64.5K Sell
8,989
-284
-3% -$2.24K ﹤0.01% 1875
2025
Q3
$99K Sell
9,273
-8,781
-49% -$86.2K 0.01% 1731
2025
Q2
$175K Buy
18,054
+18,026
+64,379% +$186K 0.02% 1212
2025
Q1
$417 Sell
28
-9,260
-100% -$142K ﹤0.01% 1955
2024
Q4
$139K Sell
9,288
-29,653
-76% -$483K 0.02% 1000
2024
Q3
$745K Buy
38,941
+28,871
+287% +$598K 0.07% 494
2024
Q2
$208K Buy
10,070
+8,259
+456% +$164K 0.03% 733
2024
Q1
$34K Sell
1,811
-9,811
-84% -$168K 0.01% 974
2023
Q4
$168K Buy
+11,622
New +$158K 0.04% 662

Other funds holding OGN

AlphaQuest's OGN Position: Q1 2026 in Review

AlphaQuest sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 8,989 shares — an estimated $64.5K sold.

AlphaQuest first reported a position in OGN in Q4 2023 and held it in 9 quarters. The position peaked at $745K in Q3 2024. 608 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • AlphaQuest reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 8,989 Organon & Co shares in Q1 2026, an estimated $64.5K.
  • AlphaQuest first reported a position in Organon & Co in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Organon & Co position peaked at $745K in Q3 2024.
  • 608 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.